rs369815468
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004260.4(RECQL4):c.1160G>T(p.Gly387Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,612,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152236Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000809 AC: 20AN: 247096Hom.: 0 AF XY: 0.0000891 AC XY: 12AN XY: 134608
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1460630Hom.: 0 Cov.: 66 AF XY: 0.0000179 AC XY: 13AN XY: 726570
GnomAD4 genome AF: 0.000446 AC: 68AN: 152354Hom.: 0 Cov.: 34 AF XY: 0.000483 AC XY: 36AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
Has not been previously published as pathogenic or benign in association with a RECQL4-related disorder to our knowledge, but was identified in an individual with a chondrosarcoma (Ballinger et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27498913) -
not specified Uncertain:1
DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.1160G>T, in exon 6 results in an amino acid change, p.Gly387Val. This sequence change does not appear to have been previously described in individuals with RECQL4-related disorders and has also been described in the gnomAD database with a population frequency of 0.14% in the African subpopulation (dbSNP rs369815468). The p.Gly387Val change affects a highly conserved amino acid residue located in a domain of the RECQL4 protein that is not known to be functional. The p.Gly387Val substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Gly387Val change remains unknown at this time. -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.1160G>T (p.Gly387Val) missense change has a maximum subpopulation frequency of 0.14% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools are inconclusive about a pathogenic or benign effect of this variant on protein function, and to our knowledge functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
RECQL4-related disorder Uncertain:1
The RECQL4 c.1160G>T variant is predicted to result in the amino acid substitution p.Gly387Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.14% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-145741246-C-A) and is interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/406906/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 387 of the RECQL4 protein (p.Gly387Val). This variant is present in population databases (rs369815468, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406906). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt RECQL4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at